Rôle des déséquilibres nutritionnels pendant la période fœtale et postnatale précoce dans le développement à l'âge adulte de l'athérosclérose // Role of nutritional disequilibrium during the fetal and early postnatal period on the development of atheroscl
ABG-128822
ADUM-62044 |
Sujet de Thèse | |
22/02/2025 | Contrat doctoral |
Sorbonne Université SIM (Sciences, Ingénierie, Médecine)
Paris - France
Rôle des déséquilibres nutritionnels pendant la période fœtale et postnatale précoce dans le développement à l'âge adulte de l'athérosclérose // Role of nutritional disequilibrium during the fetal and early postnatal period on the development of atheroscl
- Biologie
Athérosclérose, Programmation, stéatose hépatique non alcoolique
Atherosclerosis, Programming, MAFLD
Atherosclerosis, Programming, MAFLD
Description du sujet
non relevant
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
The prevalence of obesity and metabolic disorders reaches the level of global pandemic and is associated with cardiovascular diseases, which is a major cause of morbidity and mortality. Among metabolic disorders, altered circulating concentrations of lipids and lipoproteins are major components of the development of cardiometabolic diseases (CMD). This is notably the case for atherosclerosis which may lead to heart failure.
The current context of obesity and dyslipidemia is particularly worrying for women of childbearing age who are nowadays more frequently exposed to malnutrition, and especially to diets rich in saturated fatty acids, sugar and cholesterol. Indeed, in addition to impact health of the future mum, these diets may also impact the progeny. In agreement with the Developmental Origin of Heath and adult Diseases (DOHaD) hypothesis, early nutritional disequilibrium is strongly associated with the appearance of diseases in adulthood, notably the cardiometabolic ones. In addition to association observed with development of obesity or diabetes, some evidences from both familial hypercholesterolemia's cohorts and preclinical models suggest that fetuses and neonates exposed to diets rich in fat and cholesterol through their mother may be more at risk to develop atherosclerosis latter on. However, mechanisms involved are not fully understood.
Taking advantage of a dedicated preclinical mouse model with humanized lipoprotein profile, objectives of this thesis are to decipher the complex interactions between diet in future mums, regulation of the lipid metabolism, and atherosclerosis development in the progeny. In addition, since some lipid species have been associated with anti-inflammatory and cardioprotective bioactivities, the opportunity to prevent atherosclerosis development with specific nutritional complements will be evaluated. This project will involve integrated physiological (ITT, GTT), histological (IHC), biochemical (ELISA, WB) and molecular approaches (RT-qPCR) in mice. A particular attention will be paid to epigenetic modifications (meDNA, miR, Histone PTM) that could be involved. This project may offer opportunities to unveil potential new therapeutic targets and circulating biomarkers to highlight people at risk to develop atherosclerosis.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Début de la thèse : 01/10/2025
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
The prevalence of obesity and metabolic disorders reaches the level of global pandemic and is associated with cardiovascular diseases, which is a major cause of morbidity and mortality. Among metabolic disorders, altered circulating concentrations of lipids and lipoproteins are major components of the development of cardiometabolic diseases (CMD). This is notably the case for atherosclerosis which may lead to heart failure.
The current context of obesity and dyslipidemia is particularly worrying for women of childbearing age who are nowadays more frequently exposed to malnutrition, and especially to diets rich in saturated fatty acids, sugar and cholesterol. Indeed, in addition to impact health of the future mum, these diets may also impact the progeny. In agreement with the Developmental Origin of Heath and adult Diseases (DOHaD) hypothesis, early nutritional disequilibrium is strongly associated with the appearance of diseases in adulthood, notably the cardiometabolic ones. In addition to association observed with development of obesity or diabetes, some evidences from both familial hypercholesterolemia's cohorts and preclinical models suggest that fetuses and neonates exposed to diets rich in fat and cholesterol through their mother may be more at risk to develop atherosclerosis latter on. However, mechanisms involved are not fully understood.
Taking advantage of a dedicated preclinical mouse model with humanized lipoprotein profile, objectives of this thesis are to decipher the complex interactions between diet in future mums, regulation of the lipid metabolism, and atherosclerosis development in the progeny. In addition, since some lipid species have been associated with anti-inflammatory and cardioprotective bioactivities, the opportunity to prevent atherosclerosis development with specific nutritional complements will be evaluated. This project will involve integrated physiological (ITT, GTT), histological (IHC), biochemical (ELISA, WB) and molecular approaches (RT-qPCR) in mice. A particular attention will be paid to epigenetic modifications (meDNA, miR, Histone PTM) that could be involved. This project may offer opportunities to unveil potential new therapeutic targets and circulating biomarkers to highlight people at risk to develop atherosclerosis.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Début de la thèse : 01/10/2025
Nature du financement
Contrat doctoral
Précisions sur le financement
Concours pour un contrat doctoral
Présentation établissement et labo d'accueil
Sorbonne Université SIM (Sciences, Ingénierie, Médecine)
Etablissement délivrant le doctorat
Sorbonne Université SIM (Sciences, Ingénierie, Médecine)
Ecole doctorale
394 Physiologie, physiopathologie et thérapeutique
Profil du candidat
Pas de candidat pressenti
No internal candidate
No internal candidate
09/06/2025
Postuler
Fermer
Vous avez déjà un compte ?
Nouvel utilisateur ?
Besoin d'informations sur l'ABG ?
Vous souhaitez recevoir nos infolettres ?
Découvrez nos adhérents
ADEME
Nokia Bell Labs France
Institut de Radioprotection et de Sureté Nucléaire - IRSN - Siège
PhDOOC
Tecknowmetrix
CESI
Généthon
Groupe AFNOR - Association française de normalisation
TotalEnergies
SUEZ
Laboratoire National de Métrologie et d'Essais - LNE
Aérocentre, Pôle d'excellence régional
Institut Sup'biotech de Paris
MabDesign
CASDEN
Ifremer
MabDesign
ANRT
ONERA - The French Aerospace Lab